A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizumab or Trastuzumab, and With Letrozole, in Participants With Locally Recurrent or Metastatic Breast Cancer
Clinical trial NCT00960960 · COMPLETED
Trial details
- NCT number
- NCT00960960
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2015-12-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.